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Abstract
Background: Antibiotic misuse and other types of unnecessary use of antibiotics can contribute to accelerate the
process of antibiotic resistance, which is considered a global concern, mostly affecting low-and middle-income
countries (LMICs). In Mozambique there is limited evidence on community knowledge and practices regarding
antibiotics and antibiotic resistance. As part of the ABACUS project, this paper describes knowledge and practices of
antibiotic use among the general population in the semi-rural district of Manhiça to inform evidence-based
communication intervention strategies for safer antibiotic use.
Methods: The study was conducted in Manhiça, a semi-rural district of Southern Mozambique. Sixteen in-depth
interviews and four focus group discussions (FGDs) were conducted with community members to explore lay
knowledge and practices regarding antibiotics and awareness of antibiotic resistance. The qualitative data was
analysed using a combination of content and thematic analysis. The SRQR guidelines for reporting qualitative
studies was performed.
Results: Although participants did not hold any consistent knowledge of antibiotics, their visual recognition of
amoxicillin (distinct red yellow capsule) was acceptable, but less so for different types and brands of antibiotics. The
majority of participants were aware of the term ‘antibiotic’, yet the definition they gave was rarely backed by
biomedical knowledge. Participants associated antibiotics with certain colours, shapes and health conditions.
Participants reported common habits that may contribute to resistance: not buying the full course, self-medication,
sharing medicines and interruption of treatment. Most had never heard of the term ‘antibiotic resistance’ but were
familiar with the phenomenon. They often understood the term ‘resistance’ as treatment failure and likened
‘resistance’ to non-compliance, ineffective medication, disease resistance or to an inability of the physical body to
respond to it.
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Conclusion: There is a broad understanding of the importance of medication compliance but not specifically of
antibiotic resistance. In addition, there is a recognized gap between knowledge of responsible drug compliance
and actual behaviour. Future qualitative research is required to further explore what determines this behaviour. The
existing ability to visually identify amoxicillin by its distinct red and yellow appearance is informative for future
awareness and behavioural change campaigns that may incorporate visual aids of antibiotics.
Keywords: Antibiotics, Antimicrobial resistance, Community, Awareness, Mozambique
Background
Antimicrobial resistance (AMR) is considered a global
public health problem particularly affecting low- and
middle-income countries (LMICs) [1, 2]. The World
Health Organization (WHO) has long recognized AMR
(and specifically antibiotic resistance) as a growing global
health threat and considers it a high priority [3]. A driv-
ing force behind the rise in antibiotic resistance in
LMICs is their “inappropriate” use. This phenomenon
can be understood through factors on the supply side,
owing to the practice of excessive prescription, uncon-
trolled or uneven access and, on the demand side, to the
use of antibiotics [4–7].
The factors determining use of antibiotics from the de-
mand side are influenced by several aspects, including:
consumers’ lack of knowledge about appropriate antibiotic
use and its implications, as well as beliefs, expectations
and personal experiences with antibiotics [6, 8–17].
Although the evidence of absolute consumption of anti-
biotics is most numerous in high-income regions, such as
Europe, antibiotic consumption is growing the fastest in
LMICs [18]. In addition, since antibiotics can be pur-
chased without prescription in many LMIC settings, self-
medication is a common practice among consumers [8,
10–12]. A recent public awareness survey conducted in
selected regions of all continents, including sub-Saharan
Africa, south-east Asia and central America, revealed mis-
understandings about conditions treatable with antibiotics
and the concept of antibiotic resistance [3], whilst a narra-
tive review in Europe found that lack of public knowledge
and awareness one of major factors among the general
public driving antibiotic resistance [18].whilst other stud-
ies confirmed that community members lack ed. know-
ledge to differentiate between antibiotics and other
commonly used medicines [9, 12, 19–24].
In the case of Mozambique, besides the inexistence of
specific antibiotic regulation, the “Medicines law” [25]
defines the list of over-the-counter drugs that must be
updated on a regular basis. Antibiotics are not included
in this list [26], meaning that health care providers are
not allowed to dispense antibiotics without a prescrip-
tion. However, a recent study reported that antibiotics
comprised 20% of the most frequently purchased drugs
by consumers with approximately 54% of customers
purchasing the drugs without a prescription [27]. In
spite of what is legally required, a recent study con-
ducted in Maputo, concluded that the proportion of use
of non-prescribed antibiotics was higher in those who
purchased from informal markets (82.6%) [28]. Another
study conducted in the same area and focusing in infor-
mal vendors, concluded that the informal market in
Mozambique poses a serious public health risk consider-
ing that the vast majority of informal drug dispensers
(82%) have no pharmaceutical training [27]. The first of-
ficial situation analysis on antibiotic use and resistance
in Mozambique suggests that there are likely high levels
of inappropriate antibiotic use at the community level
and it recommends the rationalisation of antibiotic use
in the community as one of the strategies to reduce anti-
biotic resistance [29]. Two recent studies conducted in
Mozambique confirmed both the existence of inappro-
priate use of antibiotics at the community level and the
prevalence of self-medication via the purchase of non-
prescribed antibiotics [28, 30]. Additionally, both studies
conducted in urban areas revealed the limited knowledge
of antibiotic use that the study population held.
The limited evidence presented thus far suggests that
there is much to be done with regards to understanding
and addressing both the supply and demand-driven fac-
tors that determine inappropriate antibiotic use, yet it is
precisely in such contexts where regulations are not
enforced that the knowledge of the general public (the
demand side) can play an important role in the reduc-
tion of inappropriate use of antibiotics [9, 19, 31].
Awareness studies that evaluate lay knowledge of anti-
biotics and the factors underlying the unsafe use of anti-
biotics are considered crucial in order to inform efforts
to improve community understanding and best practices
in low-resource countries [31]. Knowledge, attitudes and
practice (KAP) studies are often a preferred method to
achieve this [6, 15, 17, 32–35]. These KAP studies focus
on the appropriate consumption, attitudes towards, and
misconceptions of antibiotics, but do not conduct in-
depth examinations of antibiotic knowledge (including
visual recognition) and tend to be methodologically lim-
ited to categorical survey data.
There is limited qualitative research published to date
regarding community knowledge of antibiotics or
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antibiotic resistance and practices regarding antibiotic
use in Mozambique, especially with regards to rural
areas. This study was designed to address this knowledge
gap. The objective of the study was to use a bottom-up
approach to describe different dimensions of community
knowledge of antibiotics and practices regarding anti-
biotic use in Mozambique from the perspective of com-
munity members so as to provide much-needed
empirical evidence for message development and posi-
tioning in the context of information, education and




This paper is based on analysis drawn from an observa-
tional mixed-methods multi-country study – the ABA-
CUS study (Antibiotic Access and Use). ABACUS
investigated ‘community-level antibiotic access and use
in 6 LMICs (Bangladesh, Mozambique, Vietnam, Ghana,
Thailand and South Africa) in order to inform the de-
sign of, and identify targets for, community-based inter-
ventions serving to promote appropriate antibiotic use
[36]. The quantitative phase of the study consisted of a
community mapping exercise coupled with an inventory
of antibiotic suppliers using a census approach, exit in-
terviews with clients of antibiotic suppliers and
community-based cross-sectional household question-
naires. The qualitative phase of the ABACUS study in
Mozambique consisted of in-depth interviews and focus
group discussions conducted with community members
and antibiotic suppliers, conducted from March 2016 to
May 2018. The results and analysis presented in this art-
icle were drawn from the qualitative component of the
Mozambican study site, although focusing only on the
community members target group.
Study site
In Mozambique, the study was conducted in the district
of Manhiça (Fig. 1), a semi-rural district covering an area
Fig. 1 Administrative Division of the district of Manhiça (Source: HDSS-CISM). Demography Department, Manhiça Health Research Centre. Map
created using ArcGIS
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of 2360 Km2 and located ~90Km from Maputo, the cap-
ital city of Mozambique. The study was implemented by
the Manhiça Health Research Centre (CISM), which
runs a Health and Demographic Surveillance System
(HDSS) covering a population of 198,000 inhabitants
registered as permanent residents and distributed across
44,000 households. Within the HDSS study area there
are 12 health centres and two hospitals; the Manhiça
District Hospital (MDH) and Xinavane Rural Hospital
(see Fig. 1) [37].
Study population
The study population are community members that live
in the district of Manhiça. The main town (Manhiça
Sede) has been a municipality since 1998. The majority
of the population lives in rural areas and most are en-
gaged in subsistence farming, labour work in sugar cane
plantations and sugar refining companies, and small-
scale businesses. The population is mainly from the Xir-
onga and Xichangana ethnic groups. Nearly half of all
women (47%) and a quarter of all men (24%) are
illiterate [38]. The study was conducted in four adminis-
trative posts (Manhiça sede, 3 de Fevereiro, Xinavane
and Maluana) to enhance geographical variety. Commu-
nity members were randomly selected within the HDSS
area based on specific criteria for each activity.
Data collection
In Mozambique, four focus group discussions (FGDs)
and 16 In-depth interviews (IDIs) were conducted be-
tween April and May 2017. The use of IDIs and FGDs
was purposively chosen for this analysis in order to gain
an in-depth understanding of the topic through triangu-
lation. The IDIs and FGDs were conducted by two
trained social science research assistants with a combin-
ation of medical and social science backgrounds to en-
sure a good balance between the capacity to engage in
in-depth discussions on social behavioural aspects and
being familiar with the biomedical implications of the
topics of interest.
In-depth interviews
This technique allowed the interviewers to maintain the
privacy and confidentially of the participants and allowed
them to comfortably express their opinions, knowledges,
experiances, and practices regarding antibiotics in detail
without the pressure of a group [39]. These interviews
were conducted one-on-one with community members
that included mothers of children under 5 years old as
well other adult male and female participants (aged > 18)
regardless of parenthood status (see Table 1). The IDIs
were performed at a time and location that provided suffi-
cient privacy; they lasted about 15–30min. They con-
sisted of open-ended questions that explored the
following themes: knowledge and awareness of antibiotics,
practices of antibiotic use, knowledge and awareness of
antibiotic resistance. Three close-ended questions were
used in addition as tools to test the consistency of individ-
ual participants’ knowledge regarding the definition and
purpose of antibiotics. Further, the interviewer displayed
a set of show-cards with the aim of assessing participants’
capacity to visually recognize antibiotics among three
commonly available pills in the study area: an analgesic
‘Paracetamol’- (circular white tablet with slot), a non-
steroidal anti-inflammatory drug ‘Ibuprofen’ (circular red
tablet without slot), and an antibiotic ‘Amoxicillin’ (cap-
sule with red and yellow lids. In addition, the interviewer
displayed show-cards to assess recognition of any anti-
biotic among five different antibiotics that are commonly
available in Manhiça: Amoxicillin (capsule with red and
yellow lids and a suspension bottle), Metronidazole (cir-
cular yellow tablet with slot), Co-trimoxazole (circular
white tablet with slot), Erythromycin (capsule with red
and yellow lids) and Azithromycin (capsules with white
lids). If antibiotics were recognized, participants were
asked whether they or their relatives had ever obtained
the antibiotics and the conditions they aimed to treat.
Focus group discussions
The focus group discussions generated discussions and
debates about the topic discussed at hand from partici-
pant’s own views [40]. Each discussion involved 6–8
participants with similar characteristics including males
and females from > 18 to < 30 and > 30 years old (see
Table 2). The FGDs were performed by two research as-
sistants, one moderator and one observer who took notes
Table 1 Target population - In-depth interviews
Target population Number of participants
Mothers of children under 5 years old 8
Males ≥18 and < 60 years old 2
Females ≥18 and < 60 years old 2
Males ≥60 years old 2
Females ≥60 years old 2
Total 16
Table 2 Target population - Focus group discussions




Females ≥18 and < 30 years old Xinavane 6
Males ≥18 and < 30 years old Maluana 6
Females ≥30 years old Manhiça Sede 6
Males ≥30 years old 3 de Fevereiro 8
Total 26
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of group dynamics and non-verbal communication. The
FGD took place in a location previously agreed with the
participants and lasted approximately 40min. The FGD
guide was structured around four thematic sections,
namely: access to treatment; suppliers of medicines; know-
ledge and practices regarding antibiotics; and antibiotic re-
sistance. The first two sections consisted of open-ended
questions. The third section started with an open-ended
question about knowledge of antibiotics supported by the
use of show-cards to assess the recognition of five antibi-
otics (the same exercise conducted in the IDI). For the
fourth section, the guide contained a hypothetical case
scenario illustrating a concrete case of resistance upon
which participants were encouraged to react, comment
and discuss. Finally, participants were asked if they had
ever heard of antibiotic resistance, its causes and
implications.
Recruitment of study participants
Different groups were selected through stratified random
sampling covering the 4 administrative posts. The IDIs
participants consisted of 8 mothers of children under 5
years of age, and a group of non-parents: two females
and two males ≥18 and < 60 years old and two females
and two males ≥60 years old. For the selection of this
target group, stratified random sampling was applied
whereby two participants that met the criteria were ran-
domly selected from each Administrative Post based on
the HDSS database. The FGDs participants were also se-
lected through stratified random sampling, however this
time sampling was based on age and gender and did not
require a proportional distribution amongst Administra-
tive Posts.
The FGD sampling frame encompassed all individuals
registered in the HDSS with study specific inclusion cri-
teria. The study intended to convey four distinct groups
of participants, namely: Females ≥18 and < 30 years old,
Males ≥18 and < 30 years old, Females ≥30 years old and
Males ≥30 years old. Each target group was randomly
matched to one of the four Administrative Posts (see
Table 2), given that the number of target groups
matched the number of existing Administrative posts
[4]. A list of potential participants that matched the tar-
get group criteria was generated from the HDSS of each
of the selected Administrative Posts. The required num-
ber of FGD discussants was randomly selected based on
the lists, including an excess of 20% to account for re-
fusals, deaths, migrations and exclusion criteria.
The research assistants approached the selected partic-
ipants for the IDIs and FGDs after identifying their
HDSS house number with the help of the local commu-
nity leader. The participants were invited to participate
in the IDI or FGD after being informed of the purpose
of the study, and the anonymous character of the
activities. For the FGDs the time and place were sug-
gested by the research assistant and agreed with the
participants.
It was required that all FGD participants came from
different households to minimize clustering of ideas and
opinions. Community members who participated in IDIs
were not eligible for inclusion in FGDs and vice-versa.
After conveying the group, eligible participants were
once again informed of the purpose of the FGD, this
time through a written participant information sheet
attached to an informed consent form that was handed
to the participants. Simultaneously, the contents of the
informed consent were read out loud to the participants
who were invited to ask questions in order to ascertain
comprehension prior to requesting them to sign it.
Data management and analysis
In-depth interviews and FGDs were conducted either in
Changana (the local dialect) or in Portuguese (the official
language) depending on participants’ preference and were
audio-recorded using digital voice recorders. Recorded
data was archived in digital format and was transcribed
verbatim and simultaneously translated to Portuguese,
when necessary, by two trained social science research as-
sistants who conducted the interviews. In order to ensure
consistency and accuracy, the most experienced team
member (senior encoder) carried out quality control by
checking the audio with the transcription to identify and
then amend any error that emerged. In addition, a matrix
was designed, where the rows represented the reference of
the participant and the columns the questions addressed
(organized into pre-determined and emerging themes.
Quotes from participants’ answers where inserted in the
corresponding cells. The qualitative data was analysed
manually following a combination of content and the-
matic analysis. The content analysis [41] began by organis-
ing and categorising the data based on pre-determined
themes (the same ones that guided the data collection
process), such as ‘awareness of antibiotics’, ‘visual recogni-
tion of antibiotics’ or ‘knowledge of antibiotic resistance’.
Within these themes some subcategories were generated
(thematic analysis), such as ‘discarding or returning medi-
cation’, ‘storing medicines for future use’ and ‘sharing
medicines’, all under ‘practices’, which were directly linked
to knowledge and practices. The process of data
immersion led to the identification of emergent themes
(thematic analysis) [42], particularly regarding local under-
standings of antibiotic resistance. All themes were con-
trasted with the data to test their consistency as well as to
identify points of tension and divergence among the dif-
ferent data collection sources and participants (triangula-
tion) [43]. The presentation of the qualitative data
(interviews and FGDs) complied with the SRQR guidelines
for reporting qualitative research [44].
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Ethical considerations
All data collection was conducted after obtaining volun-
tary, signed informed consent from each participant, as
well as permission to record individual interviews and
group discussions. Ethical approval for the study was
obtained from CISM’s Institutional Review Board (ap-
proval ref.: CISM/466/0316), followed by administrative
approval by the Mozambican Ministry of Health (ap-
proval ref.: 1487/GMS/002/016). All participants were
de-identified by only linking them to their DSS unique
identification numbers to guarantee confidentiality.
Results
The results are presented in descriptive format under
four major themes extracted from the IDIs and FGDs: (i)
General knowledge of antibiotics; (ii) Visual recognition
of antibiotics; (iii) Antibiotic use; (iv) Awareness of anti-
biotic resistance. Quotes from the respondents within
each category are presented to illustrate the findings.
Participants’ characteristics
A total of 16 community members were recruited for
IDIs, 12 of the participants were female. The age of par-
ticipants were between 18 and 29 (n = 5), between 30
and 59 (n = 6) and over 60 years (n = 5). With regards to
education, 5 participants had received no education, and
the remaining 9 participants did not completed second-
ary school and 2 did not respond. Of these respondents
9 were literate and 5 illiterate. Domestic workers and
farmers made up the majority of participants occupa-
tions (n = 6 and n = 7 respectively) (see Table 3).
A total of 26 participants were recruited for the FGDs,
with 6–8 participants in each of the four groups. The
groups were 1) adult females younger than 30, 2) adult
females older than 30, 3) adult males younger than 30
and 4) adult males older than 30 (see Table 4).
General knowledge of antibiotics
The questions on awareness and knowledge regarding an-
tibiotics begun by examining how participants freely con-
ceptualised “antibiotics”, including their recollection of the
term antibiotic, as well as their version of the definition,
the attributes and utility of the drug. The data revealed
mixed responses regarding familiarization with antibiotics.
The majority of participants who claimed to be familiar
with antibiotics were able to provide a description of this
class of drugs. The group of men ≥ 30 years old gave the
most detailed description of antibiotics, describing antibi-
otics visually as pills in the form of capsules with red and
yellow lids. Of note, participants in this group only con-
ceived of antibiotics as tablets or capsules, disregarding
the possibility of other presentations, such as oral suspen-
sion, injection or cream.
P3: I also know them...
P3: They are capsules
P2: I know antibiotics [cacophony]
P8: Me too
I: Are you able to describe what antibiotics are?
P8: Antibiotics are ‘Amoxilina’ [Amoxicillin]
P3: But we do not know them by name. They give us
those, if they are [those] or not, we have no way of
knowing...
P3: They have two colours (FGD, ≥30 years old
participants)
When questioned about the usage of antibiotics, the
majority of the participants that had heard of the term
were able to indicate the conditions they perceived to be
treated by antibiotics, which were: malaria, infections,
sexually transmitted diseases, tuberculosis, cough, fever,
body pain, stomach pain, wounds and pain in the uterus,









(18 to 35) 11 68.8




3 de Fevereiro 6 37.5
Manhiça sede 6 37.5
Subtotal 16 100
Level of education a
None 5 35.7
Incomplete primary school 3 21.4











a Two participants did not provide the level of education
b One participant did not provide the occupation
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wounds, toothache, headache, illnesses related to the
bones, rheumatism, dermatological problems, foot ail-
ments, constipation, dysentery, and mouth defects. The
vast majority of the participants in this study cited more
than one condition perceived to be treatable by
antibiotics.
Antibiotics, well I have only heard the name. They
are normally for pains like, STDs, wounds … you
see? Things like that is my understanding. (IDI, ≥30
years old participant)
The remaining participants that had also heard of anti-
biotics were not able to describe them in any sense and
claimed they did not know what they were for. Although
the majority of participants understood antibiotics as
medicines, it should be pointed out that one participant
understood antibiotics as a disease and claimed to have
never heard of antibiotics because he never got ill.
I am not really sure, I only know there are pills that
tackle infections, but knowing that this is an anti-
biotic, that that is an antibiotic … I do not know the
qualities of the pills. (IDI, ≥30 years old participant)
The perceived definition and purpose of antibiotics was
further captured through three close-ended questions.
When asked what antibiotics were, with the intention to
lead participants to talk about their purpose, there were
mixed responses, with some of the respondents reporting
that they did not know what antibiotics were, while a few
participants responded that antibiotics were drugs against
infection and others thought that they were drugs that
served to combat high blood pressure. Furthermore, the
majority of respondents reported that they did not know
what antibiotics do, while only a small minority stated that
they kill bacteria. In response to a question surrounding
antibiotic usage, most of the respondents said they did not
know what antibiotics should be used for, whilst few an-
swered that they should be taken to treat bladder infec-
tions, muscle pain or weakness.
It is important to note that none of the respondents of
the three closed-ended questions provided consistently
-sound answers, meaning that even those that did pro-
vide a correct answer, then gave a contradicting answer
to the following question. For example, of the two par-
ticipants that correctly indicated that antibiotics are used
to kill bacteria, both went on to give wrong answers to
other questions related to knowledge and purpose of
antibiotics. These responses therefore indicate inconsist-
ency in participants’ understanding of antibiotics, with
each seeming to answer each question arbitrarily (see
Table 5).
Visual recognition of antibiotics
In order to assess the extent to which participants meant
what they were verbalizing when referring to antibiotics,
two exercises using show-cards were displayed. In the








Young (18 < 30) 12 47




3 de Fevereiro 8 31
Manhiça sede 6 23
Maluana 6 23
Subtotal 26 100
Table 5 Multiple-choice questions results
Questions Optional answers Response
frequency
Percent












Don’t know 8 50%
Subtotal 16 100%





Give energy 1 6%
Kill bacteria 2 13%
Stop pain 4 25%
Don’t know 9 56%
Subtotal 16 100%
When do you think antibiotics
should
be taken?
Bladder infection 3 19%
Muscle pain 2 13%
Weakness 1 6%
Headache 0 0%
Don’t know 10 62%
Subtotal 16 100%
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first show card, participants were challenged to visually
identify an antibiotic among three commonly available
pills. A considerable number correctly identified the pic-
ture of the antibiotic (in this case, Amoxicillin), and
others pointed to the picture of Paracetamol (see
Table 6).
It is important to note that the 75% of respondents
that had previously mentioned to have already heard
of antibiotics correctly selected the photo of Amoxi-
cillin, supporting the presumption that amongst those
who claimed to know about antibiotics the mixing-up
of this concept with another class of drugs was less
likely. These participants consistently claimed to be
able to identify the antibiotic based on the shape
(capsules) and colours (red and yellow). Among those
who initially responded that they had not heard of
antibiotics, the majority did not visually identify anti-
biotics, however a few correctly did identify them.
When the second show-card with photos of five differ-
ent antibiotics was displayed (Amoxicillin, Metronida-
zole, Co-trimoxazole, Erythromycin and Azithromycin),
none of the participants recognised all five as antibiotics.
The vast majority visually recognized 1–3 of the antibi-
otics, with Amoxicillin being repeatedly the most fre-
quently recognised. To most of them, the basis for the
recognition of any antibiotic was their own, or their rela-
tives’, experience of acquiring and using antibiotics (see
Table 6).
Antibiotic use
Both the FDGs and the IDIs dedicated time to discuss
practices around antibiotic use but although questions
and probes referred to antibiotics specifically, partici-
pants mostly spoke about ‘medicines’ or ‘pills’ in general.
This aspect, coupled with the insights drawn from the
previous exercises, made clear that when discussing
practices around antibiotic usage participants were inas-
much referring to medicines in general as to antibiotics
in particular. Five themes pertaining to common anti-
biotic use practices were identified as follows.
Reasons for not purchasing the full course of medication
Participants agreed that not purchasing the full course
of medication was a common practice. According to
them, unavailability of the given medicines at the health
facility (where medicines are subsidized), led patients to
resort to private pharmacies, which are less affordable.
As a result, patients did not purchase the full course.
Therefore, medicines being out of stock and lack of
money were reported as factors resulting in purchasing
an incomplete course of treatment.
Self-medication
Some participants acknowledged that self-medication is a
common practice, particularly with over-the-counter
medication, such as ‘Paracetamol’. They explained that
sometimes one might simply have a headache which, in
their view, does not require going to the hospital. Partici-
pants also mentioned cold or flu and stomach-ache as
conditions not requiring hospital assistance and suitable
for home treatment. However they did not specify the type
of medication used in this instance therefore antibiotics
could be one of the choices since participants used the
terms antibiotic and Paracetamol interchangeably when
asked about their self-medicating practices regarding anti-
biotics. Again, this suggests that the term ‘antibiotic’ may
have been used among participants to describe drugs in
general, rather than just antibiotic drugs.
Adherence to treatment
When asked about in-depth adherence, participants rec-
ognized the importance of taking the full course of med-
ications and finalizing treatment as instructed. Few
respondents reported quitting the medication before the
prescribed treatment was completed. However, they
claimed it was important that the patient felt good be-
fore they did so. Only one participant stated they
stopped due to the “bitterness” of the drug. Participants
generally perceive that the health care provider plays an
important role in advising on treatment compliance.
I won’t deny it, sometimes I also do that [laughter], I
take pills and when I see I am better, especially if
the pills are bitter, I stop taking them, I quit. (FGD,
18 – 29 years old participants)
Storing medicines for future use
Participants unanimously denied that they buy a larger
amount of medicines than those prescribed (including,
Table 6 Responses to show-cards












Photo of antibiotic 7 44%
Don’t know 3 19%
Subtotal 16 100%
Second show-card: Does the
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but not exclusively, antibiotics). However, the majority
of participants eventually disclosed that they do recur-
rently store medicines for future use. According to them,
there are some medicines that health providers often
recommend, which can be dispensed in excess because
the pre-packaged amount of drugs within one unit (e.g.
a blister pack of tablets) often exceeds the maximum
amount prescribed. In those instances, participants re-
ferred that they keep them in case themselves or rela-
tives present the same symptoms or disease. Leftover
medicines are perceived to be mostly due to interrupted
medication rather than purchasing drugs in excess.
Yes, I buy it to take it until it finishes [but] when
there is some left and I already feel good, I keep it to
take [it] again. (IDI, ≥18 participant)
It was noticed that those participants who do keep
medicines for future use claim to only take them if it is
within the expiration date. The expiration date was men-
tioned as important criteria to consider when taking
medicines stored at home. Interestingly, most of the re-
spondents reported that it is common practice to first
take the medicines at hand and only after seek attention
at the hospital.
I keep them so that if I become ill again, if I have
them I take them … if when I take them they do not
have the same effect, [if] I feel I do not get better
even taking them [stored medication] then I go to
the hospital. (IDI, ≥18 participant)
Sharing medicines
Despite the suggestion that in this setting there is a
practice of storing medicines for future use, most partic-
ipants claimed that they do not share with, nor receive
medicines from, others, mainly because they cannot tell
whether the disease or condition to be treated is the
same. The need to go to the hospital for adequate diag-
nosis and receive the appropriate medicines was repeat-
edly emphasized.
Yet some participants did disclose that sharing medi-
cation is a common practice and that they are used to
share with, and receive medicines from, others, in par-
ticular relatives and other household members.
Here at home we are all siblings, we all have chil-
dren [so] when they have [medication] or I also have
and my son also starts with it [symptoms], they give
me and I make him take it. (IDI, ≥18 participant)
They identified two cases in which sharing medication
is justified: compatible symptoms and conditions per-
ceived as non-threatening. Regarding compatible
symptoms, this referred to cases in which medication
was shared because the receiving person had symptoms
similar to those for which the medication had originally
been prescribed and used. On the other hand, partici-
pants argued that some non-threatening conditions,
such as headaches, could be treated with stored medica-
tion that did not require prescription.
Discarding or returning medication
Participants who claimed not to store medicines for fu-
ture use revealed the habit of throwing away the
remaining medicines or, in a few cases, of returning
them to the hospital. One important factor mentioned
was that if the medicine expired it could cause other dis-
eases or even death, besides being potentially dangerous
for children’s health in the event of unsupervised
consumption.
When there are left-overs [medication], those from
the hospital, we say those are no longer useful so we
throw them away because then when you go take
them they can make you ill, even die, because it is
rotten. (FGD, ≥30 years old participants)
Awareness of antibiotic resistance
When asked directly if they had heard of antibiotic re-
sistance, respondents consistently stated that they had
never heard of the term. Amongst the few that did
recognize it, it was argued that antibiotic resistance hap-
pens when either the disease or the body resists the ef-
fects of the medication.
The hypothetical case scenario featuring a patient
seeking medical care at a hospital helped probe further
participants’ perceptions of the phenomenon. When pre-
sented with this scenario, the majority of participants
were familiar with the illustrated phenomenon, even if
they could not attribute a specific name to it.
Hypothetical case scenario:
“A person living in this community had a certain
health condition. He went to the hospital and was given
some the most appropriate medication for his condition.
He took the full course of the medicine but he did not
feel better. A few days later he went to another hospital
for the same condition and he was given the same medi-
cine that he was given at the first hospital. Once again,
he took the full course of the medicine as the doctor
instructed and still did not feel better.”
Overall, they discussed a variety of factors that could
be causing the treatment to fail repeatedly, which
branched into four overarching categories: 1) behav-
ioural, 2) physiological, 3) pharmacological and 4)
pathological.
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Behavioural: resistance as a result of sub-optimal
adherence
Participants were aware of the risk of treatment failure
and they understood that one of the main factors behind
this was sub-optimal adherence. They expressed doubts
about the extent to which what other people report in
terms of adherence correlates with what they do in prac-
tice, and felt that it is a common practice not to adhere
with the medical prescription provided, even if a patient
claims to do so. Therefore, even though the presented
scenario described a case in which adherence was prac-
ticed, most of the discussions revolved around the failure
to do so as a crucial factor leading to treatment failure.
Sub-optimal adherence was understood as not observing
the prescribed duration of the treatment, and not adher-
ing to requirements such as avoiding alcoholic drinks
and respecting the validity date.
Along the same lines, in the context of treatment suc-
cess, participants recognised the importance of observing
the treatment timeframe and mentioned “interruption of
treatment”, specifically as soon as symptoms decrease or
disappear, as a behaviour that can lead to treatment fail-
ure. Taking medications on an empty stomach was also
mentioned as a factor compromising treatment efficacy,
manifested by the patient not getting better or being
subject to additional health problems, even if the medi-
cine is taken as prescribed. According to one participant,
“this disease will stay with the person forever, even if she
takes medication correctly”. (FGD, ≥ 30 years old
participants).
When asked about the most appropriate conduct,
respondents recognised the hospital as the source of
correct treatment and emphasized the need to comply
with the treatment in order to avoid treatment
failure.
I would seek the prescription first at the doctor [isn’t
it?]... An authorized person, so they could dictate
[give orientation] it to me properly because if I go to
buy I will not know how to use ... I will use it reck-
lessly I will create more problems than those [laughs]
I had. (FGD, ≥ 60 years participants)
Physiological: resistance originating in the person’s body
Despite the fact that behavioural factors were the most
cited, one group (females ≥18 and < 30 years old) consid-
ered that the problem illustrated in the hypothetical sce-
nario was not behavioural but rather related to the
individual’s body. In addition, participants understand
that each body reacts differently, that there are particular
individual characteristics (allergies, intolerances, simul-
taneous presence of distinct diseases) that lead to
resistance.
But this is not the issue, that the pills are of poor
quality, that they don’t work, no, they do work but it
depends on each person’s organism. (FGD, 18–29
years old participants)
Pharmacological: resistance as a result of ineffective
medication
After discussing the hypothetical scenario, a few partici-
pants in the male group (≥30 years), perceived the cause
of the resistance to treatment to be rooted in the medi-
cation itself. These participants considered that, in some
cases, the medications they are given are ineffective and
are the origin of treatment failure. In this sense, the
treatment itself is considered the source of its failure.
We had those pills they called Rosoquina, Rosoquini-
nas, that did not do us good because when one took
them, often, it would cause an itch and it would
seem like one was cured even though they had not
worked. (FGD, ≥30 years participants)
Pathological: disease as the source of resistance
One participant referred to resistance as a phenomenon
that takes place in the disease itself, as a property of cer-
tain diseases that are resistant to treatment and thus lead
to its failure:
This is what causes the person to die, take the medi-
cines, pick up those diseases that are resisting, they
don’t go away, at last [you] die, [while] taking those
antibiotic tablets, the ones they say that they are
Amoxilina (Amoxicillin). (FGD, ≥30 years
participants)
This was the only participant that specifically referred
to antibiotics, as well as providing the name of a con-
crete antibiotic (Amoxicillin), when discussing resistance
to treatment success.
Discussion
To the best of our knowledge, this is the first qualita-
tive study undertaken in Mozambique aiming to de-
scribe the different dimensions of community
knowledge of antibiotics and antibiotic resistance, as
well as practices regarding antibiotic use. This aligns
with a recent statement regarding the scarcity of evi-
dence on self-medication and other aspects of anti-
biotic use in Africa [45].
In this study, we identified key dimensions that situate
participants’ knowledge of antibiotics (or lack thereof): i)
those who visually recognized antibiotics, were aware of
the term “antibiotic” and could provide some definition
based on the colour, shape and the illnesses they per-
ceived were treatable through antibiotics (even if
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inaccurate), ii) those who visually recognized antibiotics
but were unaware of the term nor could they provide
any definition linked to it, iii) those who could not visu-
ally recognize it, nor were familiar with the term, nor
could define it in any way. The majority of participants
fell into the first group.
The results from the different attempts to support par-
ticipants in conceptualizing antibiotics in their own
terms suggest that there is limited knowledge of the con-
cept “antibiotic”, as none of the participants provided an
elaborate and consistent definition of antibiotics that
does not contradict biomedical knowledge. Their con-
ceptualisation seems to have been limited by the charac-
terisation of the medicine based on the appearance and
use of the dominant antibiotic class in this setting
(Amoxicillin) which is provided as a distinct red-yellow
capsule and is also named ‘red & yellow’. Poor know-
ledge of antibiotics among the general population has
been reported in different studies in LMICs [23, 46, 47]
as well as in and high-income countries (HICs) and
amongst European populations [18]. Yet in contrast to
our study, these studies assessing the knowledge of anti-
biotics focused on their use and purpose. Our study
went further by examining participants’ familiarization
with the term and assessing the extent to which they
made a connection between the term and a definition,
be it in terms of common characteristics, use and pur-
pose, or other features. This effort also ensured, as much
as possible, that both interviewers and respondents
meant the same thing when they were referring to
antibiotics.
The limited understanding of the treatment indica-
tions of antibiotics found in this study was consistent
with existing literature [6, 20, 47, 48]. This was evi-
denced by the fact that the vast majority were unable
to specify the type of agent that antibiotics are effect-
ive against, and also that the range of diseases men-
tioned to be treatable by antibiotics was beyond the
scope of antibiotic indication. This finding correlates
with studies conducted mostly in high and middle in-
come countries (including in Indonesia, Albania, Iran
and the UK) that evaluated lay knowledge regarding
antibiotic use [15, 47, 49, 50]. Considering the literacy
limitations and low exposure to information, amongst
other factors, that act as barriers to health literacy in
poor-resourced countries such as Mozambique, our
results regarding the limited knowledge of antibiotics
are not surprising [3, 17, 46]. Moreover, although this
community has a relatively high coverage of health
services compared to other regions of the country, it
is not likely that such knowledge would be gained
through their interaction with the healthcare pro-
viders. Providers in such settings are not instructed
nor prepared to engage in dialogues with patients
beyond naming the drugs and the conditions they are
to treat. It is unlikely that providers will explain bio-
medical classifications be it in terms of pathogens
(i.e., ‘bacteria’) or descriptions of classes of drugs (i.e.
‘antibiotics’). This limited exchange has also been
found in other settings. A cross sectional study in
Malaysia shown that other general terms (such as
germs) are normally used during counselling, instead
of the microbiological term “bacteria” [19].
Despite the fact that antibiotics in Mozambique may
be presented in different pharmaceutical forms or cap-
sules of colours which may confuse the users, one im-
portant finding was the ability of some participants to
define antibiotics, influenced by their familiarisation with
Amoxicillin, which locally is typically presented in the
form of yellow and red tipped capsules. This finding is
concordant to the recent research conducted by Torres
(2019) in Mozambique, which reported that participants
reported to know Amoxicillin, describing the capsules
with in red and yellow colour [30]. Apart from limiting
their conceptualisation to an attempt to characterise
Amoxicillin, they were not able to conceptually distin-
guish antibiotics from other types of medicines. The link
to Amoxicillin may be attributed to the ample availabil-
ity and use of this antibiotic, as reported from studies in
different African countries as well as Mozambique [1,
11, 21, 27, 51–56]. This finding illustrates that if antibi-
otics have a distinct appearance, this may aid in recogni-
tion and improve use.
Looking at perceptions of the treatment purpose of
antibiotics, participants mentioned a variety of condi-
tions, including those that are not treatable by antibi-
otics. Subtle misconceptions like this could lead to
inappropriate use and potentially precipitate and/or sus-
tain the problem of resistance [3, 19, 20]. The results are
comparable to studies conducted in other LMICs [45]
and HICs [18], but also add conditions that were not
found in other studies, such as: malaria, pain in the
uterus, and mouth defects.
In alignment to studies in other settings [6, 32, 47, 57],
self-medication in addition to sharing of medication,
particularly between family members, was reported to be
a common practice in the studied communities, espe-
cially if the condition was perceived as non-threatening,
and, in the case of sharing, if symptoms were perceived
as compatible among those sharing the drug. It is likely
that such practices, reported for medicines in general,
are also applicable to antibiotics considering that the
term antibiotic was used interchangeably with the term
‘medicines’ when discussing these practices.
None of the participants in the individual interviews
seemed to be familiar with the term or the concept
of antibiotic resistance, yet the dynamics during FGDs
(which relied on participants reacting to the
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presentation of a “resistance” case scenario), allowed
participants to relate to the phenomenon and elabor-
ate on it, even though practically no one had heard
the term before. This is in accordance with a study
conducted in India, which found that none of the
participants recognised the term “antibiotic resist-
ance”, but following a brief description, some partici-
pants were familiar with the concept [46].
Respondents in our study understood the
phenomenon at a practical level (in terms of how it
manifests and plays out) and blamed resistance on
several forms of patient misbehaviour, generally classi-
fied as sub-optimal adherence to medical instructions,
but also on circumstantial aspects such as taking
medication on an empty stomach, which is not
aligned with the biomedical concept of resistance. On
the other hand, some participants related resistance
to the treatment itself not being effective due to
physiological limitations of the body (i.e., its inability
to respond to the drug), ineffectiveness of the medica-
tion itself or resistance of the diseases, regardless of
individual behaviour.
The various discussions with participants consistently
revealed that they do not associate the pathogenic agent
of the disease into the equation of antibiotic resistance,
as, in their view, it is either the result of misuse, or it is
the body, the disease or the drug itself that becomes re-
sistant, leading to treatment failure. Among these con-
ceptions, some alignment with biomedicine was revealed
with regards to the concept of antibiotic stewardship, in
which misuse leads to resistance. However, the majority
of respondents only seen at an individual level and not
at a macro, environmental level. In other words, anti-
biotic resistance affecting an individual is blamed on that
individual’s inappropriate behaviour and framed as a
phenomenon whose cause and effects are located exclu-
sively within that individual. In this way, other factors
that could lead to resistance are ruled out, including the
possibility of being infected by already carrying resist-
ance to a specific antibiotic. Attribution of antibiotic re-
sistance to the individual level, rather than an acquired
property of bacteria was also found in a study conducted
in 9 European cities [58].
Regarding stewardship, the finding on the gap between
participants’ theoretical knowledge of appropriate anti-
biotic use and their behaviour is consistent with studies
conducted in high-income countries, such as a large
household survey in Great Britain that found that 87% of
respondents who did not complete their last course also
said that a course of antibiotic should always be com-
pleted [15].
There is extensive lay knowledge built around expos-
ure to treatments and medicines, mostly as a result of
people’s own experience and the interpretation given to
such experience; this non-medical knowledge shows that
lay people do think about and conceptualize drugs in
general, within which they fit concepts around antibi-
otics and resistance in terms that are intelligible to their
own realities. In order to better reach communities and
improve community awareness it is important to reflect
on how lay people conceptualize resistance, considering
that they do not yet differentiate antibiotics from other
classes of medicines, nor do they understand fully the in-
dications of this class of drugs, even if to some extent
they are able to visually recognize a common antibiotic
by relating its image to the term ‘antibiotic’. Future cam-
paigns need to consider these lay understandings and
tackle gaps in knowledge or misinformation. This dis-
parity between lay and biomedical concepts is not to say
that a higher level of knowledge is not possible to attain
in our settings. In fact, the HIV/AIDS epidemic has
proven that complex terms such as “virus” and “anti-
retroviral” were certainly discussed with literacy-limited
community members [59–62]. A parallel could be made
with regards to the incorporation of terminologies re-
lated to “bacteria” and “antibiotics” in efforts to improve
knowledge and practices to combat antibiotic resistance.
Lastly, health policies should also consider the struc-
tural problems pointed out in this study, including self-
medication which is a result of easy accessibility, and
practices around sharing medications which is poten-
tially a result of self-diagnosis and misinformation at the
level of the supplier, be this at the hospital or pharmacy.
Given the demand side issues highlighted in this study it
is crucial for health providers to take more responsibility
in controlling access to antibiotics. Nevertheless, the
existing trust that participants in this study expressed
with regards to formal antibiotic providers represents an
opportunity for developing and targeting specific educa-
tional interventions and to inform policy to promote the
appropriate use of antibiotics.
Study limitations
Being a qualitative study, the strength of the study was
the level of depth and multiple dimensions captured
with regards to knowledge of antibiotics and antibiotic
resistance. Nonetheless, the study was designed to cap-
ture people’s ranges in perceptions and not the magni-
tude of the problem. Therefore, it has not captured how
extensive or recurrent these constructs and practices are
but rather what people consider to be common. As we
pointed out, we cannot guarantee that participants were
always referring to antibiotics throughout the interviews
and discussions since, in spite of the regular use of
prompts and visual aids to help focus the conversation
on antibiotics, respondents would often interchangeably
make reference to antibiotics and other medicines, con-
flating the two. Thus, the depth of some discussions
Cambaco et al. BMC Public Health         (2020) 20:1183 Page 12 of 15
where the term “antibiotics” was used were limited due
the fact that participants did not seem to express confi-
dence in their reference to antibiotic. Additionally, the
fact that participants knew the study was related to anti-
biotics may have induced them to use the term “anti-
biotic” more than they would have in normal
conversation when talking about medications. An add-
itional limitation of this study is the fact that, despite the
effort to discuss “antibiotic resistance” by making use of
a hypothetical scenario, participants did not use the term
“resistance to antibiotics”.
Conclusion
Limited and inconsistent knowledge about antibiotics and
antibiotic resistance were the main findings of this study.
However, participants did build some constructs around
these concepts, namely that antibiotics (mainly Amoxicil-
lin) are yellow and red capsules used to treat a non-
specific range of complaints, and that resistance refers to
the effects of sub-optimal adherence and behavioural,
physiological, pharmacological and pathological factors.
These constructs were built on the basis of their lived ex-
periences of antibiotic usage. Treatment failure is concep-
tualised at the individual level, not as a public health
concern. In addition, in spite of awareness of the import-
ance of medication compliance, participants acknowledge
it is common to not abide by it. Thus, further research to
understand this discrepancy between the knowledge of re-
sponsible medication compliance and current practices, as
well as tailored interventions that tackle inappropriate use
and behavioural change, are crucial and should be priori-
tized. The existing trust in drug providers represents an
opportunity to train and use drug providers as a medium
to communicate accurate information about antibiotic use
and resistance.
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